Experience unrivaled speed, quality and efficiency in API manufacturing when you partner with Element. Flexible, personal, cost-effective services kilo lab synthesis of tox. enabling to clinical API supplies and small-scale commercial manufacturing of APIs.
You'll benefit from a single CDMO partner throughout the product lifecycle, starting with the identification of synthetic routes for early-phase active pharmaceutical ingredient (API) supply, through small-scale commercial API supply. Solve the most challenging chemical development issues and leverage our decades of experience in the industry and proven track record of delivering complex APIs. Looking to talk about your API manufacturing needs? Start the conversation.
The 51³Ô¹ÏÍøadvantage
Make the most of our seamless, integrated service platform that allows for a single, trusted CDMO partner to support your therapeutic from discovery to commercialization.
Leverage our depth and breadth of expertise, which extends to regulatory guidance and beyond - including vast knowledge of regulatory requirements. Explore a partnership with 51³Ô¹ÏÍøtoday.
Learn more
CMC Product Development Services
Find out how our CMC development services support clinical trials and accelerate the overall drug development process for our customers
Pre-Clinical and GMP Clinical Trial Material Manufacturing
51³Ô¹ÏÍøoffers flexible, complete and seamless clinical-scale manufacturing support throughout the entire drug development life cycle, from pre-clinical manufacturing services to phase I and II clinical trial material manufacturing solutions.
Pharmaceutical Pre-Formulation & Formulation Development Services
Element’s pre-formulation and formulation development services help enhance delivery performance and stability of your parenteral, ophthalmic, and topical drug products.
Chemistry, Manufacturing, and Controls (CMC) Consulting Services
We provide consulting services for Chemistry, Manufacturing, and Controls (CMC) product development in the pharmaceutical and biotechnological industries.